Altiratinib
Drug Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Altiratinib |
| Trade Name | |
| Synonyms | DCC-2701 |
| Drug Descriptions |
Altiratinib (DCC-2701) is an inhibitor of MET, VEGFR2, TIE2, and Trk that decreases endothelial cell survival and may inhibit cell proliferation and increase cell death in tumors expressing these factors (PMID: 26965451). |
| DrugClasses | MET Inhibitor 59 Trk Receptor Inhibitor (Pan) 33 |
| CAS Registry Number | 1345847-93-9 |
| NCIT ID | C118290 |
Filtering
- Case insensitive filtering will display rows if any text in any cell matches the filter term
- Use simple literal full or partial string matches
- Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
- Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
- Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")
Sorting
- Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
- Click on any column header arrows to sort by that column
- Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Altiratinib | Altiratinib | 1 | 1 |
| Altiratinib + Bevacizumab | Altiratinib Bevacizumab | 0 | 0 |
| Altiratinib + Dabrafenib | Altiratinib Dabrafenib | 0 | 0 |
| Altiratinib + Trametinib | Altiratinib Trametinib | 0 | 0 |
CKB BOOST